Author Title Type [ Year(Asc)]
Filters: Author is Wu, Joseph C  [Clear All Filters]
Kernik, D.C., Morotti, S., Wu, H., Garg, P., Duff, H.J., Kurokawa, J., Jalife, J., Wu, J.C., Grandi, E., and Clancy, C.E. (2019). A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources.J Physiol.
Williams, I.M., and Wu, J.C. (2019). Generation of Endothelial Cells From Human Pluripotent Stem Cells.Arterioscler Thromb Vasc Biol39, 1317-1329.
Wang, L., Pegram, M.D., and Wu, J.C. (2019). Induced Pluripotent Stem Cells as a Novel Cancer Vaccine.Expert Opin Biol Ther.
Wu, H., Yang, H., Rhee, J.-W., Zhang, J.Z., Lam, C.Keung, Sallam, K., C Y Chang, A., Ma, N., Lee, J., Zhang, H., et al. (2019). Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.Eur Heart J.
Smith, A., Choi, E., Gray, K., Macadangdang, J., Ahn, E.Hyun, Clark, E.C., Laflamme, M., Wu, J.C., Murry, C.E., Tung, L., et al. (2019). NanoMEA: a tool for high-throughput, electrophysiological phenotyping of patterned excitable cells.Nano Lett.
Lau, E., Han, Y., Williams, D.R., Thomas, C.T., Shrestha, R., Wu, J.C., and P Y Lam, M. (2019). Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome.Cell Rep29, 3751-3765.e5.
Wu, J.C., Garg, P., Yoshida, Y., Yamanaka, S., Gepstein, L., Hulot, J.-S., Knollmann, B.C., and Schwartz, P.J. (2019). Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.Circ Res125, 653-658.
Abi-Gerges, N., McMahon, C., Vargas, H., Sager, P., Chui, R., Stevens, D., Davila, J., Schaub, J.R., Wu, J.C., Del Rio, C., et al. (2019). The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment.J Pharmacol Toxicol Methods106582.
Pang, L., Sager, P., Yang, X., Shi, H., Sannajust, F., Brock, M., Wu, J.C., Abi-Gerges, N., Lyn-Cook, B., Berridge, B.R., et al. (2019). Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.Circ Res125, 855-867.